Syndax Pharmaceuticals (SNDX) Stock Price, Quote, News & History | Benzinga

Syndax Pharmaceuticals Inc (SNDX) Stock Price, Quote, News & History

SNDXNASDAQ

Trade with Public

Trade with Public

$19.84

0.763.98%

At close: Aug 14, 5:00 PM EST

$19.84

N/A

After Hours: Aug 14, 4:43 PM EST

OverviewNews Earnings Forecast Events Price Targets Financials Sentiment Ownership Compare Options Stock Report

Key Statistics

Open

$19.08

Close

$19.84

Volume / Avg.

1.25M / 1.81M

Day Range

$18.82 - $19.86

52 Wk Range

12.99 - 25.59

Market Cap

$1.77B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

25.82%

Days to Cover

18.58

Recent Syndax Pharmaceuticals, Inc. News

Why Is Syndax Stock Down Today?

Shares of Syndax Pharmaceuticals, Inc. (NASDAQ: SNDX) are trading lower Friday following approval of one of its treatments from the U.S.'s Food and Drug Administration.

Alex Perry

Syndax Gains Attention With Strong Drug Portfolio, Path To Leukemia Market Growth

Syndax shares gained support after Guggenheim issued a Buy rating, citing strong Q2 results, Revuforj growth, and long-term profit potential.

Vandana Singh

This HubSpot Analyst Begins Coverage On A Bullish Note; Here Are Top 5 Initiations For Thursday

Avi Kapoor

Agilysys, Amer Sports, X Financial And Other Big Stocks Moving Higher On Tuesday

Avi Kapoor

NXP Semiconductors, Brinker International, Ultra Clean, Sanmina And Other Big Stocks Moving Lower In Tuesday's Pre-Market Session

Avi Kapoor

Financials

Quarterly

Annual

Name

Revenue Change
Gross Change
EBITDA Change
EBIT Change
Earnings Change

Cash Flows

Operating Cash Flow (TTM)

-220.64M

Investing Cash Flow (TTM)

175.48M

Financing Cash Flow (TTM)

272.88M

Free Cash Flow (TTM)

-220.87M

Capital Expenditure (TTM)

-

Net Change in Cash (TTM)

227.73M

Analyst Trends and Forecast

3

May

1

Jun

1

Jul

2

Aug

Buy

Hold

Sell

Strong Sell

Analyst Rating and Forecast

3.9

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

Valuation Metrics

Enterprise Value

$1.81B

PE Ratio (TTM)

-

PE Ratio (FWD)

-

PEG Ratio (TTM)

-

PS Ratio (TTM)

6.64

PB Ratio (TTM)

112.75

Earnings Yield % (TTM)

-13.17%

Earnings Yield % (FWD)

-10.07%

EV / EBITDA (TTM)

-

Price / EBITDA (TTM)

-

Price / Free Cash Flow (TTM)

-

Book Value / Share

$0.17

Company Debt

Total Debt

$588.12M

LT Debt

$588.12M

LT Debt Issuance (TTM)

-

LT Debt Repayment (TTM)

-

Total Cash

$336.48M

Debt to Equity

39.03

Issuance of Debt (TTM)

-

Repayment of Debt (TTM)

-

Key Statistics

Open

$19.08

Close

$19.84

Volume / Avg.

1.25M / 1.81M

Day Range

$18.82 - $19.86

52 Wk Range

12.99 - 25.59

Market Cap

$1.77B

P/E Ratio

-

Dividend Yield

-

Exchange

NASDAQ

RSI

46

Short Interest

25.82%

Days to Cover

18.58

About

Sector

Health Care

Industry

Biotechnology

Syndax Pharmaceuticals Inc is a clinical-stage biopharmaceutical company focused on developing a pipeline of combination therapies in multiple cancer indications. Its product candidates include revumenib and axatilimab. It is developing revumenib, a ...

Show More

Edge Rankings

Stock Score Locked: Want to See it?

Benzinga Rankings give you vital metrics on any stock – anytime.

Reveal Full Score

Compare

EPS worse than industry

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

Earnings Per Share

EPS is the portion of a company's profit allocated to each outstanding share of common stock. It is a key metric for investors to assess a company's profitability.

EPS worse than industry

FAQ

Q

How do I buy Syndax Pharmaceuticals (SNDX) stock?

A

You can purchase shares of Syndax Pharmaceuticals (NASDAQ:SNDX) through any online brokerage.

View our list of the best stock brokerages

Q

Who are Syndax Pharmaceuticals (SNDX) competitors?

A

Other companies in Syndax Pharmaceuticals’s space includes: AbbVie Inc (NYSE:ABBV), Amgen Inc (NASDAQ:AMGN), Gilead Sciences Inc (NASDAQ:GILD), Vertex Pharmaceuticals Inc (NASDAQ:VRTX) and Regeneron Pharmaceuticals Inc (NASDAQ:REGN).

Q

What is the forecast, or price target, for Syndax Pharmaceuticals (SNDX) stock?

A

Syndax Pharmaceuticals has a consensus price target of $37.80.

Q

What is the current price for Syndax Pharmaceuticals (SNDX)?

A

The stock price for Syndax Pharmaceuticals (NASDAQ: SNDX) is $19.84 last updated August 14, 2026 at 4:43 PM EDT.

Q

Does Syndax Pharmaceuticals (SNDX) pay a dividend?

A

There are no upcoming dividends for Syndax Pharmaceuticals.

Q

When is Syndax Pharmaceuticals (NASDAQ:SNDX) reporting earnings?

A

Syndax Pharmaceuticals does not have any upcoming earnings scheduled.

Q

Is Syndax Pharmaceuticals (SNDX) going to split?

A

There is no upcoming split for Syndax Pharmaceuticals.

Q

What sector and industry does Syndax Pharmaceuticals (SNDX) operate in?

A

Syndax Pharmaceuticals is in the Health Care sector and Biotechnology industry. They are listed on the NASDAQ.